AR012688A1 - Proceso para la preparacion de un compuesto derivado de (-)-trans-1-bencil- 3-hidroximetil-4-(4-fluorofenil)piperidina y paroxetina preparada a partirde dicho compuesto - Google Patents

Proceso para la preparacion de un compuesto derivado de (-)-trans-1-bencil- 3-hidroximetil-4-(4-fluorofenil)piperidina y paroxetina preparada a partirde dicho compuesto

Info

Publication number
AR012688A1
AR012688A1 ARP980102206A ARP980102206A AR012688A1 AR 012688 A1 AR012688 A1 AR 012688A1 AR P980102206 A ARP980102206 A AR P980102206A AR P980102206 A ARP980102206 A AR P980102206A AR 012688 A1 AR012688 A1 AR 012688A1
Authority
AR
Argentina
Prior art keywords
compound
preparation
hydroximethyl
bencil
fluorophenyl
Prior art date
Application number
ARP980102206A
Other languages
English (en)
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of AR012688A1 publication Critical patent/AR012688A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

Un proceso para la preparacion de un compuesto de formula (I) en el cual R1 representa un grupo protector de amina donde un compuesto de formula(II), en la cual R1 es como se definion anteriormente, es reducido por un hidruro de metal en presencia de una sal inorgánica, en presencia tambiénde un diluyente. Paroxetina preparada a partir del compuesto de formula (I) obtenido mediante el proceso descripto como intermediario. La paroxetina es uncompuesto que posee actividad antidepresiva.
ARP980102206A 1997-05-17 1998-05-12 Proceso para la preparacion de un compuesto derivado de (-)-trans-1-bencil- 3-hidroximetil-4-(4-fluorofenil)piperidina y paroxetina preparada a partirde dicho compuesto AR012688A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710004.4A GB9710004D0 (en) 1997-05-17 1997-05-17 Chemical process

Publications (1)

Publication Number Publication Date
AR012688A1 true AR012688A1 (es) 2000-11-08

Family

ID=10812456

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102206A AR012688A1 (es) 1997-05-17 1998-05-12 Proceso para la preparacion de un compuesto derivado de (-)-trans-1-bencil- 3-hidroximetil-4-(4-fluorofenil)piperidina y paroxetina preparada a partirde dicho compuesto

Country Status (28)

Country Link
US (1) US6326496B1 (es)
EP (1) EP0983237B1 (es)
JP (1) JP4463883B2 (es)
KR (1) KR100515852B1 (es)
CN (1) CN1121386C (es)
AR (1) AR012688A1 (es)
AT (1) ATE212013T1 (es)
AU (1) AU748902B2 (es)
BG (1) BG63847B1 (es)
BR (1) BR9809809B1 (es)
CA (1) CA2289013C (es)
CZ (1) CZ292282B6 (es)
DE (1) DE69803178T2 (es)
DK (1) DK0983237T3 (es)
ES (1) ES2171299T3 (es)
GB (1) GB9710004D0 (es)
HU (1) HUP0002709A3 (es)
ID (1) ID24181A (es)
IL (1) IL132360A (es)
NO (1) NO313326B1 (es)
NZ (1) NZ501692A (es)
PL (1) PL189464B1 (es)
PT (1) PT983237E (es)
RU (1) RU2205178C2 (es)
SK (1) SK149599A3 (es)
TR (1) TR199902823T2 (es)
UA (1) UA61952C2 (es)
WO (1) WO1998052920A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280775A1 (en) * 2000-05-12 2003-02-05 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
GB0021147D0 (en) 2000-08-30 2000-10-11 Knoll Ag Chemical process
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
JP2006512278A (ja) * 2001-06-13 2006-04-13 テバ ファーマシューティカル インダストリーズ リミティド アルコキシ不純物を実質的に含有しないパロキセチンの製造方法
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1948646A2 (en) * 2005-11-14 2008-07-30 Auspex Pharmaceuticals Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849542A (en) 1966-05-09 1974-11-19 Dow Chemical Co Lithium magnesium aluminum hydride
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
GB9100505D0 (en) * 1991-01-10 1991-02-20 Shell Int Research Piperidine derivatives
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
HUP9900318A3 (en) * 1995-05-17 2001-09-28 Novo Nordisk As Process for preparing 4-aryl-piperidine derivatives
EP0812827B1 (en) * 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
HU221921B1 (hu) 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
BR9809809A (pt) 2000-06-27
DE69803178D1 (de) 2002-02-21
CZ408199A3 (cs) 2000-04-12
DK0983237T3 (da) 2002-03-25
KR20010012620A (ko) 2001-02-26
US6326496B1 (en) 2001-12-04
CZ292282B6 (cs) 2003-08-13
SK149599A3 (en) 2000-05-16
BR9809809B1 (pt) 2009-05-05
RU2205178C2 (ru) 2003-05-27
AU7912198A (en) 1998-12-11
IL132360A (en) 2003-02-12
ID24181A (id) 2000-07-13
NZ501692A (en) 2001-05-25
KR100515852B1 (ko) 2005-09-21
BG103834A (en) 2000-07-31
BG63847B1 (bg) 2003-03-31
NO995619D0 (no) 1999-11-16
GB9710004D0 (en) 1997-07-09
DE69803178T2 (de) 2002-10-31
WO1998052920A1 (en) 1998-11-26
ATE212013T1 (de) 2002-02-15
CN1121386C (zh) 2003-09-17
JP2001525838A (ja) 2001-12-11
PT983237E (pt) 2002-05-31
HUP0002709A3 (en) 2002-01-28
PL189464B1 (pl) 2005-08-31
CN1255916A (zh) 2000-06-07
TR199902823T2 (xx) 2000-05-22
HUP0002709A1 (hu) 2001-01-29
NO313326B1 (no) 2002-09-16
CA2289013A1 (en) 1998-11-26
UA61952C2 (en) 2003-12-15
IL132360A0 (en) 2001-03-19
AU748902B2 (en) 2002-06-13
EP0983237B1 (en) 2002-01-16
CA2289013C (en) 2007-11-13
JP4463883B2 (ja) 2010-05-19
ES2171299T3 (es) 2002-09-01
PL336796A1 (en) 2000-07-17
NO995619L (no) 1999-11-16
EP0983237A1 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
EA199800140A1 (ru) Композиции с контролируемым высвобождением пароксетина
ES2159491A1 (es) Base cristalina de citalopram
NO20020214D0 (no) Substituerte oksozaheterocyklylforbindelser
AR247565A1 (es) Metodo de preparacion de compuestos de piperidina terapeuticamente activos
EA200702080A1 (ru) Полициклическое карбомоилпиридоновое производное, обладающее ингибиторной активностью в отношении интегразы вич
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
ES2185338T3 (es) Derivados de fumagilol y procedimientos para su fabricacion.
TR200100439T2 (tr) 1H-İmidazopiridin türevleri
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
DK1461318T3 (da) Tetrahydroquinolinanaloge som muscariniske agonister
AR001875A1 (es) Composición biocida que comprende una mezcla de uncompuesto de halopropinilo y una s-triazina que c ontiene azufre y método para proteger un sustrato de la infestación de hongos y algas
EA200400467A1 (ru) Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора
AR012688A1 (es) Proceso para la preparacion de un compuesto derivado de (-)-trans-1-bencil- 3-hidroximetil-4-(4-fluorofenil)piperidina y paroxetina preparada a partirde dicho compuesto
ES2190422T3 (es) Antagonistas selectivos de receptores de adenosina a2b.
MXPA04007396A (es) Proceso para la elaboracion de inhibidores de reductasa hmg-coa.
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0109176A (pt) Método para preparação de citalopram e composto da fórmula
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
MXPA02006167A (es) Promocion de la angiogenesis con survivina.
AR027559A1 (es) Metodo para la preparacion de citalopram
EA200100930A1 (ru) Способ лечения хозл
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
ES2180977T3 (es) Un derivado de 1-metilcarbapenem.
BR0106976A (pt) Método para a preparação de citalopram